Traveling with HIV — the world is still ours to see.

Travel is a right, not a risk

People living with HIV get on planes every day — to close business deals, to visit family, to snorkel a reef, to stand in a crowd of two million people during Hajj. That is the ordinary shape of life on modern antiretroviral therapy (ART). The CDC's Yellow Book, the reference U.S. clinicians use for pre-travel counseling, says it plainly: people with well-controlled HIV who are on ART and regularly engaged in care should feel comfortable traveling, because many thousands already do, every year.1

A practical travel plan covers your treatment schedule, medication supply, and destination requirements. Long-acting medicines need appointment planning too; some treatment plans still include daily pills. The sections below can help you prepare questions for your HIV clinician or pharmacist.

This guide is built around two questions travelers actually ask: What do I need to do differently because I live with HIV? and Where does the world still treat HIV status as a border issue instead of a health issue? The honest answer to the second: a changing list of countries — naming them, rather than gesturing at "some places," is what lets you plan instead of worry.

Entry restrictions in 2026 — the real list, and the real trend

Roughly 50 countries and territories still require HIV testing or otherwise restrict entry, stay, or residence based on HIV status, according to CDC's 2026 Yellow Book chapter on travelers with HIV, developed using Positive Destinations and the UNAIDS HIV-related travel restrictions database.1 Counts and categories change over time. In 2004, UNAIDS and the International Organization for Migration jointly declared HIV-related travel restrictions have no public health justification at all.1

Two dates anchor the modern history. The U.S. banned entry for people with HIV from 1987 until Congress removed the statutory language in 2008, with the remaining regulatory restrictions rescinded in 2010.1 China removed its HIV-specific entry restrictions the same year, and Namibia abolished its HIV-related immigration barriers on July 1, 2010.6 New Zealand followed in October 2021, removing HIV from its list of "high-cost" medical conditions that could trigger a residency denial — UNAIDS Executive Director Winnie Byanyima called it a step she hoped would "encourage other countries to remove all travel restrictions and other policies that discriminate against people living with HIV."2

Who still restricts entry, and how

CDC's 2026 Yellow Book lists the following countries as ones that may deport a traveler discovered to have HIV: Bahrain, Brunei, Cook Islands, Egypt, Iraq, Jordan, Kuwait, Lebanon, Malaysia, North Korea, Oman, Qatar, Russia, Saudi Arabia, Singapore, Solomon Islands, Sudan, Syria, Turkmenistan, the United Arab Emirates, and Yemen — a list that can change, so the UNAIDS and Positive Destinations databases are the sources to check closest to any trip.1

Requirements vary by destination and visa category. CDC notes that medical documentation is less commonly required for short stays, but HIV-related restrictions can affect short or long visits.1 Check the current rules for your itinerary rather than assuming a tourist visa is exempt. The U.S. State Department’s Saudi Arabia guidance distinguishes temporary visits from work and residency applications; consult the current advisory before applying.4

GNP+ has published a statement condemning HIV-related entry, residence, and medication restrictions in the United Arab Emirates.5 That advocacy statement is not a current transit clearance. Before booking a connection or visit, confirm the applicable entry and medicine-import rules with the relevant authorities, including for layovers.21

Practical implications for tourism, work visas, and long stays

Check entry, testing, and medication-import requirements before any international trip. New Zealand’s 2021 policy change is one example of why testing requirements and entry eligibility should be checked separately.2 For study, work, or residence, ask the destination’s embassy or consulate about your specific visa category and planned length of stay.1

Packing your meds — what actually crosses borders smoothly

The 2026 Yellow Book restates the packing basics with useful precision: carry HIV medications and all others in their original packaging, with labels identifying medication, dosing, and patient information.1 Bring a few extra days' supply beyond what the trip requires, and keep medications in carry-on luggage — checked bags are the ones that get lost or delayed.1

A signed clinician's letter is the single most useful document you can carry. CDC notes a healthcare professional can document that a regimen is prescribed for a medical condition without naming HIV specifically — the letter just needs to establish the medications are legitimately prescribed.1 aidsmap's traveler guidance adds that keeping your usual pill-taking routine — same meal, same rough time of day — supports adherence better than any specific packing trick.3

TSA and U.S. security screening

Medications must undergo TSA security screening; clear labels can help officers identify them.7 Reasonable quantities of medically necessary liquids may exceed the usual 3.4-ounce limit. Tell the officer before screening and separate these items, along with associated supplies, for inspection. Additional screening may be required, and an unresolved alarm can prevent an item from being allowed through. These are U.S. checkpoint rules; check destination-country requirements separately.

What NOT to do

Keep medicines in their original, labeled containers and check import rules before departure. If your supply is lost or confiscated, contact your HIV care team and insurer promptly. The nearest U.S. embassy or consulate can help locate medical services; confirm that a local provider can manage your HIV treatment. See CDC’s guidance on finding care abroad.8

Long-term stays need a different prescription strategy

For extended travel, ask your clinician about switching a 30-day prescription to a 90-day supply, and identify where you'd access HIV care at the destination if you needed a refill.1 Some countries restrict the quantity of medication that can be imported at once, so check with the destination's embassy if the stay runs past three months.1 Ask your clinic, pharmacy, and medication-assistance program early whether an advance refill is possible; confirm approval before relying on it.

Long-acting injectables and travel logistics

Long-acting HIV medicines have different roles. Cabenuva (cabotegravir/rilpivirine) is given every one or two months and can replace daily HIV treatment for eligible people. Sunlenca (lenacapavir) is an option for certain adults with multidrug-resistant HIV and must be used with other HIV medicines; its six-month injection schedule does not mean all other treatment stops.912 Apretude (cabotegravir) and Yeztugo (lenacapavir) are PrEP options for people without HIV, not complete HIV treatment regimens. Yeztugo was approved in June 2025 for twice-yearly PrEP.10

Plan injection appointments before you travel

Ask your prescribing clinic to check your trip against your injection schedule before booking. Whether you can move an appointment or use temporary oral medication depends on the product and your treatment plan. Arrange any destination clinic in advance; do not assume the medicine will be available there. Keep taking all other prescribed HIV medicines.913

Because rescheduling and cross-border clinic coordination take real time, plan the conversation with your HIV clinician 4 to 6 weeks before departure — enough runway to shift an appointment or discuss a bridging strategy without last-minute scrambling.13

Time zones and dosing — across the clock without missing a beat

Before crossing time zones, ask your clinician or pharmacist for a written schedule for your exact regimen. CDC advises considering the interval since your last dose, rather than simply switching to the destination’s clock.21 There is no single safe delay window for every HIV medicine.

• Plan both journeys: write down dose times for travel days, your stay, and the return home.
• Use reminders: set alarms to match the agreed schedule and record doses to avoid confusion.
• Check instructions: include any food requirements and what to do if a dose is late or missed.

Follow your medicine’s missed-dose instructions and your care team’s advice. Do not double a dose to catch up. Contact your clinician or pharmacist if you are unsure what to do or cannot maintain your schedule.14 For more support, see our treatment and adherence resources.

Vaccines — what's safe, what's held for CD4 count, what's new

CDC's 2026 Yellow Book, authored by Robert A. Bonacci and Eric S. Halsey, lays out vaccine guidance for travelers with HIV in detail. The underlying principle: inactivated vaccines are generally safe regardless of CD4 count, while live vaccines require a CD4 threshold because they carry a small risk of causing the disease they prevent in someone with insufficient immune reconstitution.1

Recommended for essentially everyone with HIV

Hepatitis A and hepatitis B vaccination are recommended for people with HIV who are not already immune, with post-vaccination antibody testing to confirm an adequate immune response.1 Inactivated or recombinant influenza vaccine, pneumococcal vaccination, tetanus/diphtheria/pertussis boosters, and recombinant zoster vaccine (RZV) — recommended for all people with HIV aged 18 and older, younger than the general-population recommendation — round out the routine list.1

Live vaccines and the CD4 threshold

Yellow fever vaccination requires an individual assessment of immune status, age, pregnancy, and exposure risk; a higher CD4 count alone is not automatic clearance. It is contraindicated with CD4 below 200 cells/mm³.23 If contraindicated and the itinerary can't change, CDC calls for a medical waiver plus rigorous mosquito-avoidance measures.1 For adults and adolescents, NIH advises against MMR when CD4 is below 200 cells/mm³ or HIV is uncontrolled. Your clinician should assess immunity and eligibility; pediatric criteria need a separate assessment.23 Live oral typhoid vaccine (Ty21a) and smallpox vaccine ACAM2000 are contraindicated outright for people with HIV regardless of CD4 count.1

New for 2024–2026: mpox and RSV

The mpox vaccine JYNNEOS is recommended for people with HIV who have had recent or anticipated mpox exposure; it's replication-incompetent, so it's considered safe even though effectiveness may run lower with more severe immunosuppression.1 CDC currently recommends one RSV vaccine dose for all adults 75 and older and adults 50–74 at increased risk of severe illness, including moderate or severe immune compromise. It is not currently an annual vaccine.22

Malaria prophylaxis and ART interactions

Malaria risk and disease severity are both increased in people with HIV, especially with advanced disease — CDC recommends people with a low CD4 count consider delaying travel to malaria-endemic areas, and pregnant people living with HIV should consider delaying such travel regardless of CD4 count, given how limited safe prophylaxis options become in pregnancy.1 When travel can't be deferred, effective chemoprophylaxis plus rigorous mosquito-bite precautions — treated bed nets, DEET repellents, covering clothing — are both essential and, together, highly effective.1

The antimalarial-to-ART interaction table matters because the four commonly prescribed prophylaxis options interact differently with different antiretroviral backbones, and the University of Liverpool's HIV Drug Interactions checker is the primary tool CDC itself cites for working through them.15

The bottom line: bring your full ART regimen and formulation to a travel medicine consultation, run it through the Liverpool checker with your prescriber, and don't assume your travel companion's antimalarial is automatically fine for you — the interaction differs by exact regimen.15

TB screening before and after high-burden travel

TB screening before and after travel depends on exposure risk, not HIV status or trip length alone. Healthcare work, close contact with people with TB, and prolonged stays in high-burden settings can warrant testing; high-risk exposure can also occur on a shorter trip. Discuss the itinerary and any known exposure with your clinician.16

When screening is indicated, IGRA has a practical advantage: fewer visits than TST, and less likely to produce a false positive in someone who received BCG vaccination as a child — common for people who grew up outside the U.S.16 Any positive result should be followed by a full evaluation for active TB symptoms and a chest X-ray before latent infection is assumed and treated.16 For people living with HIV, untreated latent TB progresses to active disease more readily with HIV-related immune suppression — one more reason not to skip post-travel screening if your exposure qualifies, even feeling completely well.

STIs abroad — doxy-PEP, condoms, and PrEP for a negative partner

Sexual health abroad deserves the same plain, non-judgmental treatment as any other travel health topic. Doxycycline post-exposure prophylaxis (doxy-PEP) — a single 200 mg dose taken within 72 hours after sex — is now a CDC-recommended strategy for gay and bisexual men and transgender women who've had a bacterial STI diagnosed in the past year, reducing syphilis and chlamydia by more than 70% and gonorrhea by roughly 50% in the supporting trials.17 If doxy-PEP is part of your routine, it travels like any medication: original packaging, doctor's letter if desired, and the same 200 mg-per-24-hours cap no matter the time zone.17

Condom access varies enormously by destination — reliably available in some countries, harder to find or lower-quality in others — so packing what you need rather than counting on local pharmacies is the safer default for any trip. If you're traveling with an HIV-negative partner in a mixed-status couple, PrEP — whether daily oral tablets or the twice-yearly injectable Yeztugo — should be planned with the same lead time as any other medication logistics discussed in this guide: enough runway before departure to confirm supply, refills, and (for the injectable option) whether the trip falls near an injection date.10

Insurance and getting ART if you lose your supply

Travel insurance coverage for pre-existing conditions varies. Ask explicitly whether HIV-related care, replacement medicines, and evacuation are covered, and get the answer in writing. Also check whether your usual health insurance pays for care abroad and whether separate evacuation coverage is needed.31

If ART is lost, stolen, or destroyed, contact your HIV care team and travel insurer promptly and seek a local licensed provider. The nearest U.S. embassy or consulate can help locate medical services, but a same-day refill or acceptance of a foreign prescription is not guaranteed.8 Being on the WHO essential-medicines list does not ensure a medicine is stocked locally.18 Avoid unlicensed sellers; CDC warns that medicines purchased abroad may be counterfeit or substandard.21

Discrimination and rights — working, studying, and living abroad

The line between "can I visit" and "can I stay" is where most real HIV-related travel discrimination lives. GNP+, the Global Network of People Living with HIV, is a global advocacy network run by and for people living with HIV that tracks and campaigns on travel and residence discrimination as one of its core human-rights portfolios.19

"UHC will only succeed when our voices, our leadership, and our lived experience shape the services and care we rely on to stay alive." — Florence Riako Anam, Co-Executive Director, GNP+ (Global Network of People Living with HIV), December 202519

People living with HIV and their allies have challenged discriminatory travel and residence policies for decades. GNP+’s statement on the UAE is one example of that advocacy.5

For a long-term posting, study program, or relocation, check HIV-testing requirements, permission to import ART, and access to HIV care for non-citizens. Ask about your specific destination and visa category; general information about chronic conditions may not answer HIV-specific requirements.1

Special populations — trans travelers, youth, and aging PLWH

Trans people living with HIV

Trans travelers living with HIV carry two layers of documentation planning at once: HIV-related logistics covered throughout this guide, plus gender marker and identity document consistency across passport, visa, and any secondary ID. Hormone therapy should travel under the same original-packaging, doctor's-letter principle as ART.1 Countries with the strictest HIV entry rules frequently also have the least trans-inclusive legal frameworks, so weigh destination choice with both factors in mind.

Youth living with HIV and parental logistics

For young people traveling with parents or guardians, the documentation load shifts to the accompanying adult: the clinician's letter should list medications by generic and brand name, and custody documentation may be worth carrying if the child travels without both parents. Plan school or camp travel abroad with the same 4-to-6-week clinician runway as any other trip.

Aging PLWH and comorbidity planning

Older people living with HIV are more likely to be managing comorbidities — cardiovascular disease, kidney function changes, bone density — alongside HIV, so travel medicine consultations benefit from covering the full medication list. Review RSV vaccination with your clinician: current CDC guidance covers all adults 75 and older and adults 50–74 at increased risk, including moderate or severe immune compromise.22 See our companion page on HIV and aging.

Faith-based travel — pilgrimage and HIV status

For Hajj 1447H (2026), Saudi Arabia’s Ministry of Health lists medical-fitness criteria, vaccinations, and other requirements. The published list includes severe organ failure and certain active illnesses; it does not name HIV status alone as an automatic exclusion. That is not a guarantee of individual eligibility or entry. Confirm the current pilgrimage and visa requirements with official authorities and your clinician before booking.204

The practical guidance mirrors every other section of this guide: carry ART in original packaging, bring a doctor's letter, and if any acute or opportunistic infection is active, postponing the trip is the medically sound choice — the same standard applied to any traveler with unstable illness.20 UNAIDS' broader work with faith communities has long emphasized that HIV status should never be a barrier to religious practice or community belonging.1

Emergency scenarios — theft, disaster, hospitalization, medevac

Planning for what goes wrong is not pessimism; it's the same due diligence any traveler does for a lost passport, applied to a specific, manageable scenario. Here is what actually helps in the moment:

Florida In Focus — a real departure and return hub for PLWH

Florida's geography makes it one of the country's most active gateways for exactly the kind of international travel this guide covers. Miami International Airport (MIA) is one of the busiest U.S. gateways to Latin America and the Caribbean, and Fort Lauderdale-Hollywood International (FLL) adds a second major South Florida hub — together the natural departure and return point for a large share of Florida's people living with HIV who travel to the Caribbean, Central America, and South America.

Cruise travel

Cruise ships carry their own medical logistics. Most onboard medical centers stock a limited formulary and are not positioned to manage ongoing HIV care — your full trip supply of ART needs to come with you rather than relying on the ship. Ports of call in the Caribbean vary in local HIV-related entry rules, so checking specific islands on a cruise itinerary against the UNAIDS and Positive Destinations databases before booking is worth the ten minutes it takes.6

Snowbird travel

Florida's large seasonal population — retirees and remote workers who split the year between Florida and a Caribbean or Latin American home base — faces a version of the "long-term stay" planning this guide covers, just repeated annually. Treat each seasonal move like the 90-day-plus scenario described earlier: a 90-day prescription supply where possible, a doctor's letter refreshed each season, and a check of current entry and residence rules rather than assuming last year's information still holds.1 See our companion page on finding care.